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Abstract
The biological complexity reflected in histology images requires advanced approaches for unbiased prognostication.
Machine learning and particularly deep learning methods are increasingly applied in the field of digital pathology.
In this study, we propose new ways to predict risk for cancer-specific death from digital images of
immunohistochemically (IHC) stained tissue microarrays (TMAs). Specifically, we evaluated a cohort of 248 gastric
cancer patients using convolutional neural networks (CNNs) in an end-to-end weakly supervised scheme indepen-
dent of subjective pathologist input. To account for the time-to-event characteristic of the outcome data, we
developed new survival models to guide the network training. In addition to the standard H&E staining, we investi-
gated the prognostic value of a panel of immune cell markers (CD8, CD20, CD68) and a proliferation marker
(Ki67). Our CNN-derived risk scores provided additional prognostic value when compared to the gold standard
prognostic tool TNM stage. The CNN-derived risk scores were also shown to be superior when systematically com-
pared to cell density measurements or a CNN score derived from binary 5-year survival classification, which ignores
time-to-event. To better understand the underlying biological mechanisms, we qualitatively investigated risk heat
maps for each marker which visualised the network output. We identified patterns of biological interest that were
related to low risk of cancer-specific death such as the presence of B-cell predominated clusters and Ki67 positive
sub-regions and showed that the corresponding risk scores had prognostic value in multivariate Cox regression ana-
lyses (Ki67&CD20 risks: hazard ratio (HR) = 1.47, 95% confidence interval (CI) = 1.15–1.89, p = 0.002;
CD20&CD68 risks: HR = 1.33, 95% CI = 1.07–1.67, p = 0.009). Our study demonstrates the potential additional
value that deep learning in combination with a panel of IHC markers can bring to the field of precision oncology.
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Introduction
A tumour and its microenvironment consist of vari-
ous cell types which interact in complex ways
[1]. In addition to cancer cells, immune cells of
both lymphoid (e.g. cytotoxic T cells) and myeloid
lineage (e.g. macrophages) can be found in the
tumour stroma. The distinct composition of cells
and their interaction with each other are thought to
play an important role in tumour development,
tumour growth, metastasis and patient prognosis in
various cancer types [2,3].
© 2020 The Authors. The Journal of Pathology: Clinical Research published by The Pathological Society of Great Britain and Ireland & John Wiley &
Sons, Ltd.
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Traditionally, pathologists estimate quantities of cell
types, such as Ki67 positive cells for the grading of
neuroendocrine tumours, by counting positive cells in
a predefined number of selected fields of view [4]. In
some tumour types, classification systems such as
grading, scoring and tumour subtyping allow for prog-
nostication. However, such approaches suffer from
subjectivity, intra- and inter-observer variability and
are biased by prior knowledge [5].
With the recent boost in deep learning methodology,
time-consuming and tedious tasks such as cell and
region detection/classification are increasingly being
automated [6–8]. Deep learning models such as con-
volutional neural networks (CNNs) learn a hierarchical
set of filters (convolutions), guided by a so-called ‘loss
function’ that measures the difference between ground
truth and predictions.
Instead of using knowledge-based features (based
on the detected regions and cells) for patient stratifica-
tion, end-to-end learning aims at directly associating
images with survival data. Accordingly, the loss func-
tion needs to take into account the characteristics of
survival data, i.e. the non-Gaussian distribution and
censoring events. Straightforward dichotomisation
based on the median survival or regression on survival
time ignores either time or event. In contrast, Cox
regression models the influence of covariates on sur-
vival via the proportional hazards condition [9]. In
classical Cox regression models, features are linearly
combined and complex non-linear relationships are
neglected. Faraggi and Simon were the first to replace
the linear form by a non-linear neural network as input
in the loss function based on the Cox model (Cox loss)
and applied their network to a prostate cancer
dataset [10]. Yousefi et al demonstrated that deep sur-
vival models in combination with Bayesian optimisa-
tion can be successfully applied in a large-scale
genomic profile project [11]. In a study by
Mobadersany et al, patient outcomes were predicted
from H&E-stained whole slide images of gliomas
using a CNN that was driven by a Cox loss [12]. In
another study, Bychkov et al trained recurrent archi-
tectures to directly predict colorectal cancer outcome
based on haematoxylin and eosin (H&E)-stained tissue
microarray (TMA) images using cross-entropy loss
(5-year survival) [13]. As an alternative to minimising
the Cox loss, Mayr et al proposed optimising the con-
cordance index for time-to-event data to identify
molecular signatures with gradient boosting [14,15].
In the study presented here, we used CNNs to auto-
matically learn time-to-event outcomes from TMA
images from a Japanese patient cohort with gastric
cancer. Advancing previous work, which focused on
H&E sections, we analysed immunohistochemical
(IHC) stains for CD8 (cytotoxic T cells), CD20 (pan-B
cells), CD68 (pan-macrophages) and Ki67 (proliferat-
ing cells) by training CNNs with three different
survival-specific loss functions: (1) the Cox loss, (2) a
new CNN-adapted concordance loss and (3) a new
loss that maximises the logrank test statistic.
Our CNN-derived risk scores made a significant
contribution in multivariable Cox regression and out-
performed cell density features as well as scores
derived from models using binary (median cancer-
specific survival time) classification. Computing risk
heat maps allowed us to identify tissue regions associ-
ated with low or high risk for cancer-specific death.
Materials and methods
Patient cohort
In total, the dataset consisted of digital images of IHC
stained TMAs from 248 patients from a gastric cancer
patient cohort with locally advanced disease who had
surgery at the Kanagawa Cancer Center Hospital,
Yokohama, Japan [16].
Two tissue cores (1.2 mm diameter each) from an area
of highest tumour cell density were used for TMA con-
struction and served as our regions of interest. The 4 μm
TMA sections were stained for the immune cell markers
CD68 (pan-macrophages), CD8 (cytotoxic T cells) and
CD20 (pan B cells); the proliferation marker Ki67; and
H&E, as described previously [16]. Sections were scanned
at ×40 magnification using an Aperio XT (Aperio Tech-
nologies, Vista, CA) digital slide scanner. All artefacts
such as air bubbles, blurry regions and folds were manu-
ally annotated and excluded from analyses. After quality
control, 90% of patients had two cores available for each
stain, the remaining 10% a single one. We used cancer-
specific survival time from surgery for analyses (median
follow up time 86 months, range from 3.3 to 150 months).
As patients in this cohort were either treated by surgery
only or surgery followed by adjuvant chemotherapy, we
confirmed that there was no interaction between our risk
scores and treatment using Cox regression analysis. Clini-
copathological characteristics of the cohort can be found
in supplementary material, Table S1. Studies were
approved by Local Research Ethics Committees.
Technical workflow: from TMA images to risks
In this study, we aimed to identify survival related fea-
tures from images. The data and high-level workflow
overview are shown in Figure 1. Image patches
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(160 × 160 pixels at ×20 magnification corresponding
to 80 × 80 μm) were extracted from the TMA cores in
the training set for each stain and fed into the CNN
training. During training, risk-relevant features were
automatically extracted in the CNN layers. The last,
fully connected layer then returned for each patch a
single risk value that was related to patient cancer-
specific survival. The learning process was guided by
a specific loss function, which considered the time-to-
event and censoring status. In addition to the Cox loss,
we developed two new CNN loss functions: the ‘Uno
loss’ which maximised the concordance index and the
‘Logrank loss’ which optimised the logrank test statis-
tic. Trainings were performed for each stain
separately.
During prediction, unseen TMA cores from the test
set were tiled into patches and forwarded in the CNN.
To aggregate data to patient level, we restricted our-
selves to computing only the median risk score of all
patches per patient and stain, which avoids multiple
testing issues (median as a descriptive statistic of the
risk distribution, see supplementary material,
Figure S1). Two stains were combined by adding their
respective single stain risk values. Due to the medium
size of the patient cohort (n = 248) and the lack of an
independent validation set, we used a pre-validation
procedure to assess the performance of different IHC-
associated risk factors (see supplementary material,
Figure S2).
Deep learning: network training and prediction
As network architecture, we used a slightly modified
GoogLeNet [17] to tradeoff network size against
reported classification accuracy considering our cohort
size and computational costs (see supplementary mate-
rial, Appendix S1.1). For the same reason, we did not
tune the network architecture or patch size and reso-
rted to default values. In the default version, the next
to the last layer defines a 1024-dimensional feature
vector x. We changed the final fully connected layer
from a 1000 class output to a single output. x is then
multiplied by a weight vector β ϵ ℝ1024 to give the sca-
lar risk value xTβ.
Loss functions
All three of the following loss functions take into
account that survival data are a composite of a survival
time T and an event status (deceased or censored).
Cox loss: In case of the Cox model, the loss is given
by the negative log partial-likelihood of the survival
data given the image patches (see supplementary mate-
rial, Appendix S1.2 for more details).
Uno loss: This loss is based on the concordance
index C - index = P(ri > ri|Ti < Tj), where ri, rj are the
risks for case i, j and Ti, Tj are the corresponding
cancer-specific survival times. The C-index is 1 in the
case of perfect ordering and 0.5 for random sorting.
Uno et al proposed a consistent and asymptotically
normal estimator of the C-index which we employed
for our loss function [14]. In contrast to Mayr et al
[15], we did not use gradient boosting with linear base
learners but used non-linear CNN to retrieve the fea-
ture vectors xi, xj from the input image patches (see
supplementary material, Appendix S1.3 for more
details).
Logrank loss: The logrank test is a non-parametric
test to compare right-skewed and censored survival
data. As loss function, we resorted to its test statistic,
which we transformed into a smooth function. The
input feature vectors which enter the loss function
were again retrieved by forward passing the image
Figure 1. (A) TMA images acquired from a Japanese gastric cancer cohort. (B) All cores of a given patient are tiled into patches. Both
survival time and event are forwarded from the patient to the patch level. (C) A convolutional neural network is trained to predict sur-
vival risks from a given input patch. Parameter estimation is guided by one of three survival loss functions: Cox, Uno or Logrank loss.
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patches (see supplementary material, Appendix S1.4
for more details).
Cell densities
To compare the prognostic value of our CNN-derived
scores with a conventional cell segmentation approach, we
segmented individual cells and classified them into marker
positive or marker negative. Segmentation was done by
identifying foreground regions via maximally stable
extremal regions (MSER) [18] followed by the application
of geometric descriptors such as convex hull-based filter-
ings. Subsequently, the detected objects were classified
into marker positive or negative by their mean blue to red
ratio. Next, a slide-specific visual context random forest
was trained on these classified candidates to return poste-
rior maps to perform the final detection steps [19]. Positive
cell densities were calculated as the number of positive
cells per patient divided by the core area per patient. For
combined features, two such densities were either multi-
plied or added.
Statistical analyses
We included age, gender, body mass index (BMI), histo-
logical phenotype according to Lauren classification,
TNM or pT, which is more locally confined than TNM,
as co-variables into the multivariable Cox regression.
The significance level for statistical tests was chosen as
0.05. To assess the prognostic value of our risk scores
(median value of all patches per patient), we stratified
patients into low-risk and high-risk using the median
cohort risk score as a threshold. Kaplan–Meier curves
were generated and the difference in survival between
the low-risk and high-risk group was assessed by the log-
rank test. Risks from two different stains were combined
by adding them (see supplementary material, Appen-
dix S1.5).
Statistical analyses such as univariable and multivari-
able Cox regressions and logrank tests were performed
using the R package survival (v2.41.3). CNN training
and prediction were run in TensorFlow/keras (v.1.10.0)
on a NVidia K80 graphics card (see supplementary mate-
rial, Appendix S1.6 for more details).
Results
Risk heat map analysis
Similarly to Yousefi et al [11], we used risk heat maps
to visualise structures in the images which the network
has learned to associate with specific risks. During pre-
diction, each TMA core was tiled into patches and each
patch was forwarded through the network. The final
layer returned the risk of the respective patch, which was
then used for a colour-coded transparent overlay onto the
original image (ranging from green for low risk to red
for high risk). These risk maps allowed a pathologist to
visually evaluate the network output thereby enabling the
identification of patterns of interest and to compare
regions with different risks.
Overall, the risk maps for the Cox/Uno/Logrank
losses were visually comparable, as shown for a repre-
sentative core in Figure 2A. Across all markers, epi-
thelial regions were easily distinguishable due to a
consistently higher risk compared to other regions
such as stroma and immune cell clusters.
Qualitative analysis of the risk maps for CD20
images identified regions of tumour stroma with high
densities of CD20(+) cells to be associated with lower
risks than stromal regions with low densities of CD20
(+) cells (see Figure 2B). B cell clusters were consis-
tently assigned low risks, as shown in Figure 2C. Epi-
thelial regions devoid of CD20(+) cells were identified
as high risk (see Figure 2B), while infiltrating B cells
lowered the risk (see Figure 2C).
In CD68 images, epithelial regions were associated
with high risks tending towards lower risks in the pres-
ence of infiltrating CD68(+) cells, as depicted in
Figure 2D. In contrast, tumour stroma densely popu-
lated with CD68(+) or CD68(−) immune cells was
identified as low risk. The same applied for immune
cell clusters. They often contained only few CD68(+)
cells, and comparison with the corresponding
CD20-stained core revealed that the clusters were fre-
quently dominated by B cells (see Figure 2E).
The interpretation of Ki67 associated risk maps was
challenging due to the fact that both epithelial and
immune cells can be Ki67 positive. Visual inspection
suggested that immune cells were rarely Ki67 positive
in this cohort. Epithelial regions with high percentages
of Ki67(+) tumour cells were mostly associated with
higher risks in comparison with regions dominated by
Ki67(−) tumour cells (see Figure 2F). As seen in
Figure 2G, lymphocytes in the tumour stroma, mainly
Ki67(−), were detected as low-risk structures compared
to the tumour epithelium. Similarly to CD68, immune
cell clusters were predicted as low risk in Ki67-stained
images (see Figure 2H). Only very few of these
immune cells were Ki67(+), but they were often CD20
(+) as confirmed visually.
Qualitatively, CD8 risks turned out to be inversely
correlated with the density of epithelium-infiltrating
CD8(+) cells. Additionally, immune cell clusters,
partly CD8(+), were confirmed to be low-risk regions
as for the other markers.
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Figure 2. Risk maps for the markers CD20, CD68 and Ki67 with low and high risks indicated in green and red, respectively.
(A) Comparison of risk maps for the different loss functions for a core stained for CD20. (B,C) Representative risk maps for CD20.
(B) Tumour epithelium is associated with a higher risk than stroma with a low density of CD20(+) cells. Stroma densely populated with
CD20(+) cells has an even lower risk. (C) B cell clusters as well as CD20(+) cells infiltrating the epithelium are regarded as low risk. (D,E)
Representative risk maps for CD68. (D) A high risk is predicted for epithelial cells with a tendency towards lower risks in regions infil-
trated by CD68(+) cells. Infiltrated stroma is associated with low risks independent of CD68(+) cell densities. (E) Immune cell clusters
that may contain CD68(+) cells are associated with low risks. Visual inspection of the corresponding core stained for CD20 reveals B cell
clusters. (F,G,H) Representative risk maps for Ki67. (F) Epithelium is associated with high risks, with a decreased risk for regions domi-
nated by Ki67(−) cells compared to Ki67(+) cells. (G) Immune cells in the stroma are linked to low risks. (H) Immune cell clusters (mostly
Ki67(−) cells) are detected as low-risk regions. They are often B cell clusters as revealed by comparison with the corresponding region
stained for CD20 (not shown). If not stated otherwise, risks for the Uno loss are shown. Scale bars indicate 100 μm.
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Stratification of the cohort with CNN-based risk
features
The results from univariable cancer-specific survival anal-
ysis for all single stains (CD8, CD20, CD68 and Ki67)
and pairs of stains for each loss function are summarised
in Table 1. We observed that for CD8 and Ki67 none of
the loss functions generated a significant patient stratifica-
tion, whereas the Cox loss was able to stratify the cohort
with all other univariable and bivariable scores. Figure 3
shows corresponding Kaplan–Meier curves for the three
most significant P values using the Cox loss.
All three loss variants returned consistent prognostic
logrank test outcomes. P values for both Ki67- and
CD8-associated risk scores were non-significant
irrespective of the type of loss function (all p > 0.05). In
contrast, CD20- and CD68-associated risks had similar
significant P values. Regarding combined risks,
Ki67&CD8 was still only slightly below 0.05 for two of
the three loss functions. Linking Ki67 with CD20 ret-
urned better P values than the single markers.
CD8-associated risks decreased the prognostic values of
CD20 and CD68. Combining CD20 and CD68 instead,
which already performed well as individual scores, even
improved the stratification (Uno: CD20: p = 0.0055,
CD68: p = 0.007 versus CD20&CD68: p = 9.22e−5).
Hence, scores involving CD20- or CD68-associated risks
outperformed the ones involving CD8.
Correlation to clinical covariables
To further investigate the association between our IHC-
based risk scores and cancer-specific survival while cor-
recting for other clinical covariables, we performed multi-
variable Cox regressions. We included age, gender, BMI,
histological phenotype according to Lauren classification
(categorised as intestinal, diffuse or mixed) and TNM (see
supplementary material, Table S2). Kaplan–Meier curves
for the cohort stratified by TNM are shown in supplemen-
tary material, Figure S3. Whereas the survival CNN was
restricted to information extracted from locally confined
TMA cores from the primary tumour, the clinicopatholog-
ical variable TNM additionally included information from
regional lymph nodes (pN) and distant metastasis (pM).
As shown in Table 2, combined risks including Ki67,
CD20 and/or CD68 had hazard ratios (HRs) significantly
larger than 1, including in the presence of the clinical
covariables (Ki67&CD20: HR = 1.364, p = 0.013;
CD20&CD68: HR = 1.338, p = 0.009; Ki67&CD68:
HR = 1.473, p = 0.002; all for Logrank loss). Age, gender
and BMI never appeared as relevant factors and thus are
omitted in Table 2 (see supplementary material,
Tables S3.1–3.4 for the complete tables). As expected,
TNM stage was significant (stage III versus stage II:
HR > 3.091, p < 0.8.2e−5). In each Cox regression result,
Logrank loss-based risk scores and Uno loss-based risk
scores outperformed Cox risk scores. Similar to the
median-based logrank test results, single-marker risks for
Ki67 and CD8 were either not or only slightly significant
(see supplementary material, Table S3.2).
For comparison with pT as a more locally con-
fined feature, TNM was replaced in a second analy-
sis by pT whereas all other covariables were kept.
pT is a categorical variable that can take one of the
following values: pT1a/b, pT2, pT3, pT4a/b. To
avoid numerical instabilities in the Cox regression
fitting process caused by low group sizes, we
grouped pT1a/b and pT2 (early cancer) as well as
pT3 and pT4a/b (advanced cancer). In this setting,
risk scores turned out to be more significant than pT
category (see supplementary material, Table S3.3).
Survival analysis on H&E images
Previously published studies on automatic survival
learning were based on H&E-stained
images [12,13]. While these images are widely
available, specific cell types such as lymphocytic
subpopulations are not distinguishable from H&E-
stained images. We performed an analysis analogous
to those for single IHC stains on the corresponding
H&E-stained TMA images. Table 3 presents multi-
variable Cox regression results with the H&E risks
being non-significant. Including pT instead of TNM
led to a slightly significant H&E risk score for the
Cox loss (see supplementary material, Table S3.3).
Inspection of the risk maps revealed lymphocytes as
low-risk regions whereas tumour epithelium, as expected,
was predicted to be high-risk (see supplementary
Table 1. Logrank test P values for single and combined risk
features for all three losses.
Logrank test P values
Risk/loss Cox Uno Logrank
Ki67 ≥0.05 ≥0.05 ≥0.05
CD8 ≥0.05 ≥0.05 ≥0.05
CD20 0.0159 0.00549 0.0108
CD68 0.02 0.00707 0.0157
Ki67&CD8 0.0268 ≥0.05 0.0374
Ki67&CD20 <0.001 0.00536 0.00397
Ki67&CD68 0.00697 <0.001 0.00277
CD8&CD20 0.0390 0.0376 ≥0.05
CD8&CD68 0.0196 ≥0.05 ≥0.05
CD20&CD68 0.00847 <0.001 <0.001
The cohort was split into low-risk and high-risk arms based on the respective
median cohort risk score per stain. Significant P values (<0.05) are shown in
bold font.
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material, Figure S4). Yet, compared to IHC-stained
images, H&E focuses mainly on morphological charac-
teristics of cells and tissues, preventing a more detailed
subtyping of cells.
Comparison to classification loss and classic cell
density analysis
Binary 5-year survival classification
Instead of a specific survival loss function, a common
approach is to use a classification loss for training. More
precisely, the outcome is binarised by thresholding sur-
vival times based on e.g. the 5-year survival time. Draw-
backs are the disregard of certain censored cases as well
as the loss of time information. In our cohort, 90 patients
were censored within the first 5 years and therefore
excluded from the analysis. To compare our survival
CNN to a 5-year survival classification, we trained and
evaluated analogously, but changed the loss function to a
cross-entropy loss.
For the commonly used 5-year survival classification,
we found both univariable and multivariable Cox regres-
sion results to be non-significant irrespective of the
staining (see supplementary material, Table S3.4). In total,
these risk maps appeared to be significantly less detailed
and precise, thus underpinning the need for a survival-
specific loss (see supplementary material, Figure S5).
Prognostic factors derived from cell densities
A commonly reported feature is cell density, e.g. the
density of CD8(+) cells as the number of these cells
per unit area. Given more than one cell type, densities
can be combined arithmetically, e.g. multiplied. We
used an automatic cell segmentation algorithm [19] to
segment and classify all cells into marker positive and
negative. Subsequently, we computed the average den-
sities of marker positive cells in the TMA cores for
Figure 3. Kaplan–Meier plots (Uno loss) showing stratification of the cohort into low- and high-risk arms. The groups were retrieved by
thresholding the respective feature based on the cohort median.
Table 2. HRs for multivariable Cox regressions including the respective risk and TNM stage. Results for age, gender, BMI and Lauren
classification are not shown as they were not significant (see supplementary material, Table S3.1).
Multivariable Cox regression
Cox Uno Logrank
HR 95% CI P value HR 95% CI P value HR 95% CI P value
CD20&CD68 risk 1.356 1.0, 1.84 0.049 1.27 1.02, 1.57 0.029 1.338 1.07, 1.67 0.009
TNM stage III versus II 3.342 1.9, 5.86 <0.001 3.34 1.91, 5.84 <0.001 3.231 1.84, 5.66 <0.001
TNM stage IV versus II 6.851 2.98, 15.78 <0.001 6.628 2.86, 15.34 <0.001 6.56 2.87, 15.0 <0.001
Ki67&CD20 risk 1.282 0.94, 1.74 0.113 1.259 1.01, 1.57 0.04 1.364 1.07, 1.74 0.013
TNM stage III versus II 3.327 1.93, 5.75 <0.001 3.269 1.9, 5.63 <0.001 3.167 1.84, 5.46 <0.001
TNM stage IV versus II 7.251 3.4, 15.45 <0.001 7.058 3.3, 15.09 <0.001 7.065 3.31, 15.06 <0.001
Ki67&CD68 risk 1.463 1.07, 2.01 0.018 1.444 1.14, 1.82 0.002 1.473 1.15, 1.89 0.002
TNM stage III versus II 3.251 1.85, 5.71 <0.001 3.091 1.76, 5.42 <0.001 3.177 1.82, 5.56 <0.001
TNM stage IV versus II 7.198 3.19, 16.23 <0.001 7.252 3.23, 16.3 <0.001 7.255 3.21, 16.41 <0.001
Significant P values (<0.05) are in bold.
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CD8, CD20, CD68 and Ki67. Moreover, we defined
combined arithmetic features, such as CD20(+) cell
density × CD68(+) cell density.
Multivariable Cox regression rendered all cell densi-
ties as non-significant with CD8 having the lowest
P value (Table 4; see supplementary material,
Table S3.2 for pT included instead of TNM).
Discussion
This study presents a novel deep learning method to cor-
relate cancer-specific survival with image patches
acquired from IHC-stained tissue sections. Like previous
work performed on large H&E stained image datasets,
the proposed method delivers unbiased prognostic infor-
mation without use of pathologist’s knowledge. In our
study, IHC-derived risk scores enabled better prognosti-
cation than H&E-derived scores. In the training of the
CNN model, so-called Cox [10], Uno and Logrank loss
functions were employed, which provide several mathe-
matical approaches to rank survival risks in a way coher-
ent with the observed time and event data. To the best of
our knowledge, we are the first to propose both Uno and
Logrank loss.
The method can be applied to various cancer types
and stains and allows for the creation of new biologi-
cal insights and suggestions for therapeutic targets.
Moreover, in addition to IHC, other omics data could
be integrated into the CNN.
Quantified by the logrank test, we obtained significant
P values for survival risks associated with CD20 and
CD68 stained sections, while CD8 and Ki67 turned out to
be non-significant in a univariable analysis. Moreover,
adding survival risk scores from two IHC sections consis-
tently improved the power of stratification. Combinations
of Ki67&CD20, Ki67&CD68 and CD20&CD8 showed
the lowest P values using all three loss functions.
In multivariable Cox regression analyses,
Ki67&CD20, Ki67&CD68 and CD20&CD68 related
risks had HRs significantly larger than one, even with
the covariable TNM included. Interestingly, the average
densities of marker-positive cells were not significant in
the Cox regression. This could be explained by the abil-
ity of the CNN to learn spatial patterns in the images
comprising not only marker-positive, but also marker-
negative cells as well as additional components of the
tumour microenvironment.
The proposed method utilised both survival time and
event to compute the respective loss function. To com-
pare with an approach which classifies patients into
short- and long-time survivors, we employed a standard
cross-entropy loss function. This required the removal of
censored short time survivors and resulted in non-
significant survival predictions, emphasising the need to
deal properly with censored cases.
Due to their intrinsic complexity, a comprehensive and
transparent interpretation of CNN internals is frequently
prohibitive. Yet, for survival CNNs, the output of a
trained network can be inspected visually using a sur-
vival risk heat map, for which each image patch is
colour-coded using its associated survival risk. A pathol-
ogist’s assessment of those risk maps indicated that the
survival CNN learned to characterise tumour epithelium
Table 3. HRs for multivariable Cox regression for H&E risks.
Multivariable Cox regression – H&E
Cox Uno Logrank
HR 95% CI P value HR 95% CI P value HR 95% CI P value
Age 1.0 0.98, 1.02 0.976 1.0 0.98, 1.02 1.0 1.0 0.98, 1.02 0.998
Gender 0.875 0.55, 1.39 0.57 0.875 0.55, 1.39 0.572 0.875 0.55, 1.39 0.571
BMI 0.932 0.86, 1.0 0.066 0.93 0.86, 1.0 0.06 0.931 0.86, 1.0 0.064
Lauren intest. 0.742 0.46, 1.2 0.223 0.741 0.46, 1.2 0.221 0.74 0.46, 1.2 0.219
Lauren mixed 0.661 0.26, 1.68 0.385 0.638 0.25, 1.63 0.347 0.646 0.25, 1.64 0.36
TNM stage III versus II 3.326 1.95, 5.66 <0.001 3.391 1.99, 5.77 <0.001 3.371 1.98, 5.73 <0.001
TNM stage IV versus II 7.251 3.42, 15.38 <0.001 7.232 3.4, 15.39 <0.001 7.306 3.43, 15.56 <0.001
H&E risk 1.273 0.86, 1.88 0.222 1.234 0.9, 1.69 0.187 1.149 0.86, 1.54 0.357
Significant P values (<0.05) are shown in bold font. Histological tumour type (Lauren): intestinal (intest.) versus diffuse or mixed versus diffuse.
Table 4. HRs for multivariable Cox regression for CD8 cell density.
Multivariable Cox regression – CD8 cell density
Variable HR 95% CI P value
Age 1.001 0.98, 1.02 0.882
Gender 0.876 0.55, 1.4 0.579
BMI 0.946 0.88, 1.02 0.148
Lauren intest. 0.678 0.42, 1.11 0.119
Lauren mixed 0.546 0.21, 1.43 0.217
TNM stage III versus II 3.314 1.92, 5.72 <0.001
TNM stage IV versus II 6.833 3.17, 14.71 <0.001
CD8 cell density 0.817 0.66, 1.02 0.074
Significant P values (<0.05) are shown in bold font. Histological tumour type
(Lauren): intestinal (intest.) versus or mixed versus diffuse.
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without infiltrating immune cells as high-risk regions. In
contrast, stromal regions, particularly if densely infiltrated
by immune cells, were associated with low risks. In addi-
tion, intra-epithelial immune cells lowered the survival
risks of tumour regions. These findings are consistent
with the notion that tumour-infiltrating immune cells are
associated with reduced cancer growth and progression.
Regarding specific stains, qualitative analysis of the risk
maps for CD20 revealed that high densities of
CD20-positive B-cells in the intra-tumoural stroma or
within the tumour epithelium were associated with low
risks in this gastric cancer cohort. In addition, B-cell clus-
ters were identified by the survival CNN as low-risk
regions. Few publications have investigated the role of B-
cells in survival prognosis in gastric cancer to date. How-
ever, there are hints in the literature that B-cells in tertiary
lymphoid follicles are associated with a favourable prog-
nosis in Japanese gastric cancer [20]. Moreover, a meta-
analysis of more than 30 studies demonstrated that gastric
cancer patients with a high density of tumour-infiltrating
B-cells had a better disease-free survival [21].
Visual assessment of CD68-positive macrophages
residing in tumour epithelium or within the tumour
stroma revealed an association with a lower survival
risk. This observation is in contrast to a meta-analysis of
19 studies showing that macrophages do not have a sig-
nificant effect on survival in gastric cancer – however
the studies were not restricted to Asian cohorts
[22]. Thus, this needs further investigation, e.g. by using
specific stains to distinguish M1 from M2 macrophages.
Epithelial regions with high percentages of
Ki67-positive proliferating cells were associated with high
survival risks. However, the survival risks based on Ki67
were not prognostic in univariable analysis. In contrast to
other indications like colon cancer [23], the prognostic
value of Ki67 in gastric cancer is controversial in the litera-
ture; while several publications declare that high Ki67
expression is an indicator of poor prognosis [24–26], one
paper claims the opposite [27] and still others state that
Ki67 does not provide significant prognostic value [28,29].
In agreement with previous publications [21], the
CNN associated a high density of tumour-infiltrating
CD8-positive cytotoxic T-cells with low risks. Since the
CD8-associated survival risks were not prognostic in the
univariable analysis, it would be interesting to investigate
markers like Granzyme B or PD-L1/PD-1 to determine if
fractions of cytotoxic T-cells lack cytolytic functions or
are exhausted, respectively.
There are limits and potential extensions to this work.
Compared to whole slide resections, the TMA cores only
capture a fraction of the whole picture, in particular with
respect to the tumour microenvironment. The same is true
for the limited number of IHC stains in this study. Various
additional markers such as CD4, FOXP3 and CD163 as
well as dual stains to capture the interplay between differ-
ent cell populations may provide deeper insights. Spatial
alignment of all sections would be ideal to enable a com-
bined analysis, but is challenging; thus, multiplexed
immunofluorescence or novel methods such as imaging
mass cytometry may provide a convenient alternative.
Although we need to validate the findings of this work
using an independent patient cohort, the workflow and
methods described open a novel way for unbiased bio-
marker discovery. In particular, the machine learning-
driven analysis of high-dimensional multiplex data,
which are non-trivial to interpret for pathologists, will be
of interest. Within the deep learning methodology, this
approach shifts the role of the pathologist from providing
ground truth annotations towards biomedical interpreta-
tion of the learnings of a survival network using risk
heatmaps. While this work is largely consistent with
existing pathology knowledge, the deep survival learning
approach in general may enable new evidence-based
diagnostic applications for the benefit of cancer patients.
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